Fundraising Fox
aMoon
Venture capitalRa'anana · Seed–Late Stage · 33 people tracked
Also known as AMOON VENTURES Y.SH. LTD.
Find your way into aMoon
Each arrow is one introduction. Sign up to fill in the first one.
Ask Ophira Stein to introduce you to Yair Schindel
You →Ophira · together at MAOZ מעוז →Yair
Ask Jamie Chen to introduce you to Reut Shema
You →Jamie · together at Weizmann Institute of Science →Reut
Ask Sam Okafor to introduce you to Roy Wiesner
You →Sam · together at Hutchison Kinrot →Roy
- Todd Sone655 people can intro you
- Adam Kotzen392 people can intro you
- Tamir Maixner362 people can intro you
Sign up to find every way you can get introduced to aMoon
- Your email: who you already know at aMoon, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the aMoon team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
aMoon invests in early- and late-stage companies harnessing groundbreaking science and technology to address high unmet medical needs. Through its aMoon Velocity (early-stage) and aMoon Growth (late-stage) strategies, the firm backs disruptive solutions across biotech, medtech, digital health and healthtech. Its in-house aMoon Alpha team supports portfolio companies with talent placement, ecosystem bridges to co-investors, research institutions, payers, providers and large biopharma/medtech/tech corporations, and proprietary market intelligence. aMoon is staffed by scientists, physicians, entrepreneurs and investors with global experience, and aims to make healthcare more affordable, higher quality and more accessible while partnering with CEOs committed to transforming healthcare.
Source: firm website, verified Sep 29, 2026.
Team · 33 people
from the firm's website & public directories
What they invest in
from 42 of 62 portfolio companiesHealthtech ×26Biotech ×25Digital Health ×18AI & Machine Learning ×13Medical Devices ×9Deep Tech ×7Mental Health ×4Enterprise Software ×3
HQs:United States×22Israel×3United Kingdom×2Switzerland×1
Who they back
founder profiles across 19 portfolio companiesFounding team size:solo founder×92 founders×53 founders×5
Where their founders studiedfrom 18 founders with education data
Ben-Gurion University of the Negev ×2Harvard Medical School ×2University of Oxford ×2
What their founders studiedfrom 21 founders with field-of-study data
Business & Management ×6Life Sciences ×6Economics ×3Medicine ×3Computer Science ×2Engineering ×2Finance & Accounting ×2Mathematics & Statistics ×2
Where their founders worked beforefrom 19 founders with career history
Iora Health ×3IDEO ×2
6 founders hold a PhD · 3 hold an MBA (of 22 with degree data)
Investments · 62 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 62024 · 42023 · 22022 · 32021 · 52020 · 62019 · 72018 · 136 dated
Adicet Bio develops allogeneic gamma delta CAR T cell therapies for patients with autoimmune diseases and cancer.
BiotechHealthtechMenlo Park, US
Aya Jakobovits(Executive Officer, Director)Nathan Hubbard(Executive Officer)inChen Schor(President, Chief Executive Officer and Director)in
BoardJonathan Silverstein(Director)inCarl Gordon(Director)inFlorent Gros(Director)
Board seatYair Schindel· per SEC Form D · $80M raise · filed Oct 2019
Co-investorsForesite CapitalOrbiMedPontifax Venture CapitalQuan CapitalNovartis Venture FundPureTech Health
Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.
Digital HealthHealthtechWellness & FitnessSan Francisco, US
Andrew DiMichelle(Executive Officer, Director)Adrian James(Founder)inSean Duffy(Founder)inWei-Li Shao(President)inSteve Cook(Chief Financial Officer)inAndrew DiMichele(Founder)
Co-investorsAndreessen HorowitzBlackbird VenturesCanvas VenturesCivilization Ventures Management, LlcDesigner FundEnsemble Labs+18 more
.jpeg){kind=logo}
Seer develops proteomics tools for large-scale protein analysis, including an assay, automation instrument, and analysis software for studying the proteome across human and non-human samples.
BiotechDeep TechHardwareHealthtechBoston, US
Omid Farokhzad(Founder)inPhilip Ma(Executive Officer)Shadi Aryanpour(Executive Officer)David Singer(Director)Omid Cameron Farokhzad(Founder)in
BoardTerrance McGuire(Director)
Co-investorsSoftBank Vision FundSolasta VenturesWingMaverick VenturesPolaris PartnersT. Rowe Price
Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data.
BiotechDigital HealthFemTechHealthtechSalt Lake City, US
Douglas Fisher(Executive Officer)Jay Moyes(Executive Officer)inGregory C. Critchfield(Executive Officer, Director)inAndrew A. Sauter(Executive Officer)inZhenya Lindgardt(President and Chief Executive Officer)in
BoardMansoor Mirza(Director)
Co-investorsExcelestar VenturesIntermountain HealthOUP (Osage University Partners)UpStart VenturesVivo CapitalCatalyst Health Ventures+1 more
Smith+Nephew is a medical technology company that develops products for the repair, regeneration, and replacement of soft and hard tissue, including sports medicine solutions for treating sporting injuries.
HealthtechMedical DevicesSports TechLondon, GB
Thomas James Smith(Founder)Horatio Nelson Smith(Co-founder)Deepak Nathin
Co-investorsAccelmed PartnersAccess Venture PartnersAlphaDrivePeregrine VenturesTargeted Technology Funds
Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology.
BiotechHealthtechMedical Devices
Jack Elands(Founder & CEO)inXavier Preville(Co-founder, VP & Head of Research & Preclinical Development)inJan H.M. Schellens(Chief Medical Officer)inThierry Menguy(VP & Head of CMC Operations)inJaime Arango(Chief Financial Officer)inPaul Jackson(Chief Operating Officer)in
Co-investorsRA CapitalBpifranceAndera PartnersAngelini VenturesKurma PartnersPontifax Venture Capital+1 more
Breeoot is a concierge preventive medicine practice where a single primary physician manages a patient's complete health picture across multiple specialties, coordinated through a technology platform designed for continuous care rather than episodic visits.
Digital HealthHealthtechLongevityWellness & Fitness
David Reichman(Co-founder)
Co-investorsIneffable Ventures
Character Bio is a patient-driven therapeutics company that combines genomics, longitudinal clinical and imaging data, and machine learning to identify genetic drivers of disease progression and develop new treatments, with a focus on polygenic diseases.
AI & Machine LearningBiotechDigital HealthJersey City, US
Cheng Zhang(CEO, Co-Founder)inMarcel van der Brug(Scientific Advisor, Co-Founder)inNick Johnson(Technology Advisor, Co-Founder)inDaniel Elgort(Chief Data and Analytics Officer)inLaura Carter(Chief Scientific Officer)inRobert Kim(Chief Medical Officer)in
Co-investorsLuma GroupSanofi VenturesInnovation EndeavorsCantos VenturesCatalio Capital Management, LPDuke Capital Partners+5 more
Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing total outflow through the uveoscleral pathway to treat glaucoma.
BiotechHealthtechMedical DevicesElkins Park, US
Tsontcho Ianchulev(Executive Officer, Director)Sean Ianchulev(Founder & Chairman of the Board (CMO))inMichael Haydin(Executive Officer)
BoardJeffry K Weinhuff(Director)Farrell Tyson(Director)Stephen Bloch(Director)in
Co-investorsVisionary VenturesCanaan PartnersCivilization Ventures Management, LlcFemHealth VenturesJSD Capital, LLCUS Venture Partners
MDClone provides a healthcare data platform that uses synthetic data to support clinical research and care-improvement initiatives, used by health systems such as Intermountain for programs targeting chronic conditions like kidney disease, diabetes, and cardiovascular disease.
AI & Machine LearningData & InfrastructureDigital HealthHealthtech
Ziv Ofek(Co-Founder and President)inBruno Lempernesse(Chief Executive Officer)inAaron Galaznik(Chief Medical Officer)inAlmog Ohayon(Chief Product and Technology Officer)in
Co-investorsLightspeed Venture PartnersOrbiMedWarburg PincusDeclaration PartnersViola Ventures
Scipher Medicine is a precision immunology company that combines molecular data from autoimmune patients, protein interaction mapping, and AI to match patients with the most effective therapy for immunological diseases.
AI & Machine LearningBiotechDigital Health
Joseph Loscalzo(Founder)Albert-László Barabási(Founder)
Co-investorsKhosla VenturesAlumni VenturesB3 HoldingCobalt VenturesEcho Health VenturesHitachi Ventures+2 more
Better Life Partners provides same-day medication-assisted treatment for opioid and alcohol addiction, combining counseling, community support, and medication for people in recovery.
Digital HealthHealthtechMental HealthHanover, US
Adam Groff(Executive Officer, Director)inJuliana Ekong(Executive Officer, Director)Myechia Minter-Jordan(Director)Steven Kelly(Executive Officer)
Board seatYair Schindel· per SEC Form D
Co-investorsAlumni VenturesF-Prime Capital.406 VenturesMaverick Ventures
Satellite Bio develops an off-the-shelf cell therapy that delivers functional liver cells (hepatocytes) into the body, where they engraft to restore liver function.
BiotechHealthtechCambridge, US
Christopher Chen(Director, Promoter)inThomas Lowery(Executive Officer)
BoardEllie McGuire(Director)Ling Wong(Director)Sujata Bhatia(Director)William Young(Director)
Board seatYair Schindel· per SEC Form D
Co-investorsAlumni VenturesCatalio Capital Management, LPLightspeed Venture PartnersHighbury HoldingsPolaris PartnersS32
Viracta Therapeutics was a precision oncology company.
BiotechHealthtechCardiff, US
James Woody(Director)David Slack(Executive Officer)
BoardIvor Royston(Executive Officer, Director)Patrick Soon-Shiong(Director)Richard Ghalie(Director)
Board seatGur Roshwalb· per SEC Form D · $40M raise · filed Dec 2020
Co-investorsAisling CapitalLatterell Venture PartnersVirtus Inspire Ventures
Quanterix (operating together with Akoya) develops biomarker measurement platforms that combine ultrasensitive blood/CSF liquid immunoassays with spatial tissue proteomics for research and clinical use in neurology, oncology, inflammation, cardiology and infectious disease.
BiotechDigital HealthMedical DevicesBillerica, US
Brian McKelligon(Executive Officer)Garry Nolan(Director)Matthew Winkler(Director)
BoardRob Hart(Executive Officer)inRobert Shepler(Director)inThomas Raffin(Director)in
Co-investorsTelegraph Hill Partners
AltruBio develops antibody-based therapeutics for immunological and inflammatory diseases, with clinical-stage candidates (ALTB-268 and ALTB-168) targeting conditions such as ulcerative colitis, psoriatic arthritis, psoriasis, and acute graft versus host disease.
BiotechHealthtech
Co-investorsDelos CapitalRA CapitalBiotechnology Value FundSoleus Capital
Ayala Pharma is associated with pharmaceutical drug candidates including AL102, AL101, and BST-236; the page states that AL102 and AL101 were acquired by Immunome, Inc. in Q1 2024.
Biotech
Co-investorsIsrael Biotech Fund
Biolojic uses artificial intelligence and machine learning to design programmable antibodies that can dynamically sense and respond to specific patient micro-environments.
AI & Machine LearningBiotechDeep Tech
Yanay Ofran(Founder & CEO)in
Co-investorsOurCrowdWestern Technology Investment
Connie Health helps older Americans choose and navigate Medicare plans by combining technology with local licensed agents, providing unbiased plan recommendations and an ongoing local care team at no cost to the user.
Digital HealthHealthtechInsurTech
Oded Eran(Founder)inDavid Luna(Founder)inMichael Scopa(Founder)in
Co-investorsAbstract VenturesJ-VenturesNat TurnerArkitekt Venturesat.inc/HealthQuest Capital+4 more
Curesponse applies science and technology to improve cancer treatment, bringing together medical executives, scientists, and clinical and regulatory experts.
AI & Machine LearningBiotechDigital HealthHealthtech
Guy Neev(Co-Founder & CEO)inDr. Ravid Straussman(Scientific Founder)Dr. Seth Salpeter(Co-Founder & CTO)Eran Dor(CFO)
Co-investorsNCL Technology Ventures Ltd.
Eleos offers life insurance and income protection to consumers in the UK, with an app-based process that explains cover in plain English, provides instant answers, and connects users to licensed experts by WhatsApp, email, or phone.
FintechInsurTech
Co-investorsArkin CapitalFuel VenturesHeartfelt CapitalInsurTechEight Roads VenturesF-Prime Capital+4 more
Eleos develops AI-powered software that helps behavioral health clinicians deliver more effective care through data measurement and personalization.
AI & Machine LearningDigital HealthHealthtechMental HealthCambridge, US
Alon Joffe(Founder)inDror Zaide(Founder)inAlon Rabinovich(Founder)inDenny Morrison(Chief Clinical Officer)inRaz Karmi(Chief Information Security Officer)inNoam Cohen(VP of R&D)in
Co-investorsArkin CapitalArkin Digital HealthF-Prime CapitalGreenfield PartnersLool VenturesMaccabee Ventures+3 more
GK8 developed self-managed digital asset custody technology for institutions, including a patented air-gapped cold vault and MPC-based wallet infrastructure.
Crypto & Web3CybersecurityFintech
Lior Lamesh(Founder)in
Co-investorsCV VCIN VentureiAngelsIsrael Innovation Authority
GraphiteRx operates a marketplace platform that connects pharmacies, hospitals, clinics, and suppliers to streamline healthcare distribution.
AI & Machine LearningB2B MarketplacesEnterprise SoftwareHealthtech
Co-investorsBowery CapitalHumans Of The InternetLool VenturesNew Era Capital Partners
iGentify provides a platform combining patient engagement and clinical data management for healthcare providers.
AI & Machine LearningDigital HealthHealthtech
Co-investorsEsplanade VenturesLIP Ventures BoutiqueSilvertech VenturesWorld Trade Ventures (WTV)OurCrowd
Uses proprietary technology to unmask cancer and recruit a targeted immune response.
Co-investorsCancer FocusPeregrine Ventures
Lin Health provides virtual, evidence-based behavioral healthcare for people with chronic pain, using the Collaborative Care model and a technology platform to address the underlying causes of pain rather than only symptoms.
Digital HealthHealthtechMental HealthWellness & Fitness
Yehuda Kogan(Founder)in
Co-investorsLIP Ventures BoutiqueSaban VenturesShoni Health VenturesViola VenturesMayo Clinic VenturesOsage Venture Partners+1 more
Lutris Pharma develops targeted skin protection treatments for cancer patients, combining clinicians and scientists with oncology expertise.
BiotechDigital HealthHealthtechMedical Devices
Antoni Ribas, M.D., Ph.D.(Founder and Chairman of the Board)Sumant Ramachandra(Chief Executive Officer and Board Director)inJonathan Benjamin(Clinical Development Lead)
Co-investorsPeregrine VenturesPontifax Venture CapitalArkin CapitalColumbus Venture Partners
Lyfegen provides a software platform for managing value-based and outcome-based healthcare contracts and drug pricing agreements between pharmaceutical companies, health insurers (payers), and providers.
Digital HealthHealthtechSaaSBasel, CH
Girisha Fernando(CEO & Founder)inMichel Mohler(CFO & Founder)Nico Julian Mros(CXO & Founder)in
Co-investorsAPEX VenturesTX Ventures
MOBILion Systems develops the MOBIE platform, a high-resolution ion mobility mass spectrometry (HRIM-MS) instrument that separates and identifies complex molecules in separation science.
BiotechDeep TechHardwareExton, US
MELISSA SHERMAN(Executive Officer, Director)in
BoardJASON SMITH(Director)inMICHAEL ALBIN(Director)JUDIT LOSONCZI(Director)HEINER DREISMANN(Director)
Co-investorsAnzu PartnersArgonautic VenturesiSelect FundCultivation Capital
NanoGhost develops a drug targeting platform called Nano-Ghosts (NGs), nanovesicles made from the cell membrane of mesenchymal stem cells that target cancer and inflammation sites and can carry various therapeutic loads.
BiotechDeep TechHealthtech
Marcelle Machluf(Professor (technology inventor))
Omada is an AI-powered marketing platform that automates organic growth for local businesses through social media management, Google Business Profile optimization, content creation, and lead capture without requiring paid advertising.
AI & Machine LearningMarketing TechSaaS
Andrew Miller (Mounier)(Founder)in
Co-investorsCrosslink CapitalHubSpot VenturesMotier VenturesBlumberg CapitalFoundersX VenturesGradient Ventures+1 more
Plexium is a targeted protein degradation company developing small molecule therapeutics for treating diseases with high unmet medical needs using their proprietary DELTA Discovery platform.
AI & Machine LearningBiotechDeep TechSan Diego, US
Michael Martin, Ph.D.(Chief Executive Officer, President)Jorge F. DiMartinoinMichael Martin(President, Chief Executive Officer)inStephen Mullennix(Executive Officer)in
BoardSerge Messerlian(Director)inCariad Chester(Director)in
Co-investorsCRV (Charles River Ventures)DCVC (Data Collective)M VenturesNeotribe VenturesPivotal Life SciencesSoftBank Vision Fund+3 more
Positive Development provides autism therapy and developmental care services for neurodivergent children and their families.
Digital HealthHealthtechMedical DevicesMental HealthMclean, US
Mike Suiters(Executive Officer, Director)inNick Whitehead(Director)in
BoardAdam Seabrook(Director)inDaniel Gebremedhin(Director)John Banta(Director)inBrenton Fargnoli(Director)in
Co-investorsAlleyCorpB Capital GroupB4 CapitalFlare Capital PartnersLifeforce CapitalObvious Ventures+3 more
.jpeg){kind=logo}
PrognomiQ is a clinical-stage company developing blood-based tests for early detection and treatment of cancer and other complex diseases using multi-omics data.
AI & Machine LearningBiotechHealthtechSan Mateo, US
Philip Ma, Ph.D.(Executive Officer, Director)Philip Ma(Chief Executive Officer & Founder)inOmid Farokhzad(Chair of the Board of Directors)inDavid Siewers(Chief Financial Officer)inBrian Koh(Chief Medical Officer)inBruce Wilcox(Chief Technology Officer)in
Co-investorsCatalio Capital Management, LPWingMaverick Ventures
Seer provides a platform for sales associates in luxury retail to create and share customized lookbooks and style recommendations with clients.
Enterprise SoftwareRetail TechSaaSSan Francisco, US
Christina Czap(Founder)inFelipe Saint-Jean(Founder)in
Co-investorsOpen Opportunity FundPioneerY CombinatorEsas VenturesFoundation CapitalGlobal Founders Capital+4 more
SOPHiA GENETICS develops the SOPHiA DDM data analytics platform for genomic and multimodal data analysis, offering solutions used in oncology research and in vitro diagnostics.
AI & Machine LearningBiotechDigital HealthMedical Devices
Jurgi Camblong(Founder)Lars Steinmetz(Founder)Pierre Hutter(Founder)
Co-investors360 CapitalBalderton CapitalCompoundHitachi VenturesACE & CompanyAlychlo+2 more
Theranica develops non-invasive, drug-free wearable therapeutic devices for pain treatment, combining neuroscience research with mobile digital technology.
Digital HealthHealthtechMedical Devices
Alon Ironi(Founder)in
Co-investorsLionBirdVivo CapitalLightspeed Venture Partners
Ultima Genomics develops genomic sequencing technology to scale omics information for advances in biology and human health improvements.
BiotechDeep TechHealthtechMedical Devices
Gilad Almogy(Founder)in
Co-investorsAndreessen HorowitzKhosla VenturesLightspeed Venture PartnersPlayground GlobalPotentum PartnersFounders Fund+1 more
YISSUM is a technology transfer organization founded in 1964 that commercializes research from the Hebrew University, connecting groundbreaking academic innovations with industry partners and global markets.
AgTechAI & Machine LearningBiotechDeep TechEnterprise SoftwareJerusalem, IL
Co-investorsPix Vine Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
DZZOM DelawareHometown Medical HoldingsAdicetAir DoctorBiosplice TherapeuticsBreeoot ClinicCartiHealCAVOSColtac TherapeuticsDayTwoHopscotch Primary CareIBEXLin HealthMetaSightMetaSight DiagnosticsMiNA TherapeuticsNectin TherapeuticsPacegenixSmart Medical SystemsTheranicaZebra Medical Vision
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 7
5 IPOs · 2 acquisitionsAdicet BioNASDAQ: ACETOmada HealthNASDAQ: OMDASeerNASDAQ: SEERSera PrognosticsNASDAQ: SERASmith+NephewNYSE: SNNAkoya Biosciencesacq. by QuanterixGK8acq. by Celsius Network
Portfolio news
latest coverage across their companiesConnie Health · finsmes.com · Jun 18, 2026
Eleos · fintech.global · Apr 13, 2026
Lin · prnewswire.com · Dec 9, 2025
Iantrek · globenewswire.com · Aug 20, 2025
Positive Development · finsmes.com · Aug 6, 2025
Frequently asked questions
- How many investments has aMoon made?
- aMoon has 62 tracked investments, 7 of which have exited, including 9 dated in the last 24 months.
- What stage does aMoon invest at?
- aMoon invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does aMoon focus on?
- aMoon focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is aMoon located?
- aMoon is headquartered in Ra'anana, IL.
- Does aMoon lead rounds?
- aMoon has led 7 of the 13 rounds where its role is on record.
- Who does aMoon co-invest with?
- aMoon most often shares deals with Lightspeed Venture Partners, Peregrine Ventures, Alumni Ventures, among 116 tracked co-investors.
- What size deals does aMoon back?
- Across 20 deals with disclosed amounts, aMoon has joined rounds of $8M – $190M (median $48.5M).
Media · Podcasts & interviews
from their channelaMoon Portfolio Spotlight: MiNA Therapeutics
aMoon Fund
aMoon Portfolio Spotlight: Satellite Bio
aMoon Fund
aMoon Portfolio Spotlight: SOPHiA GENETICS
aMoon Fund
aMoon Portfolio Spotlight: MDClone
aMoon Fund
Meet the aMoon Advisors
aMoon Fund
aMoon Velocity
aMoon Fund
Images
Co-investors · 17
Lightspeed Venture Partners is a global venture capital firm that backs founders from Seed through Series F and beyond, emphasizing deep, immersive partnerships with the companies it invests in.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.
Polaris Partners is a venture capital firm that partners with biotech and healthcare entrepreneurs to build transformational companies.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Viola is an Israeli technology investment group managing over $7 billion in assets, operating multiple independent investment arms spanning venture capital, growth equity, credit, and fintech.
S32 is a venture capital firm investing at the frontiers of technology, backing exceptional founders with conviction-based investing led by experienced partners.
Vivo Capital is a global healthcare-focused investment firm operating a multi-strategy platform spanning venture capital, private equity, and public equity. It aims to expand healthcare access and drive innovation through its 'Ecosystem Strategy.'
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Highbury is a venture capital firm that invests in, advises, and builds early-stage companies across frontier sectors. The firm takes concentrated positions and maintains long-term partnerships with founders solving compounding problems.
▶5 more co-investors
.406 Ventures10DEcho Health VenturesNorthpond VenturesMaverick Capital
Firms observed investing alongside aMoon, from public investor directories. Shared companies are the overlap with aMoon's recorded portfolio.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
ARTIS Ventures is a venture capital firm investing in breakthrough companies at the convergence of technology and biology, with a focus on healthcare and life sciences ('TechBio'). It backs founders across biotech, therapeutics, digital health, and frontier technologies.
Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.